FOXD3 and breast cancer: After identification of a cytoplasm-distribution of FOXD3-AS1 in BC cells, the bioinformatics analysis and luciferase assays collectively suggested that FOXD3 binds to miR-363 and is able to diminish its suppressive effects on TFF1 mRNA.